Prevention of vascular access hand ischemia using the axillary artery as inflow  by Jennings, William et al.
From the Society for Vascular SurgeryFrom
M
Auth
Pres
th
Rep
of
O
The
to
m
0741
Cop
httpPrevention of vascular access hand ischemia using
the axillary artery as inﬂow
William Jennings, MD, Robert Brown, MD, John Blebea, MD, MBA, Kevin Taubman, MD, and
Ryan Messiner, DO, Tulsa, Okla
Background: Avoiding dialysis access-associated ischemic steal syndrome (DASS) in patients with upper extremity
peripheral vascular occlusive disease while creating a functional hemodialysis vascular access may be challenging. We
constructed an autogenous access with primary proximalization of the arterial inﬂow to prevent hand ischemia in patients
at high risk for this complication.
Methods: Patients requiring hemodialysis access with physical ﬁndings suggesting a high risk of access-related hand
ischemia (absent radial, ulnar, and brachial palpable pulses associated with small calciﬁed vessels by ultrasound exami-
nation) underwent a primary arteriovenous ﬁstula transposition procedure utilizing the axillary artery for inﬂow. The
arteriovenous ﬁstula was either a reversed ﬂow basilic vein transposition supplemented by valvulotomy (n [ 22);
a translocated reversed basilic vein (n[ 4); a cephalic vein harvested into the forearm and placed in a loop conﬁguration
for axillary artery inﬂow (n [ 3); or a translocated reversed saphenous vein (n [ 1).
Results: Thirty patients with a mean age of 60 years (range, 31-83 years) underwent successful primary axillary artery
inﬂow procedures during a 3-year period. Of these, 23 (77%) were female and 25 (83%) were diabetic. Twenty-one (70%)
had previous vascular access procedures and 10 (33%) were obese. No patient developed postoperative ischemia. Three
individuals died 2, 14, and 19 months following surgery, none related to vascular access. Three accesses failed after 1, 5,
and 7 months and could not be salvaged. Life-table primary, primary assisted, and cumulative patency rates were 57%,
78%, and 87% respectively at 1 year with a mean follow-up of 7 months (range, 1-25 months). Cephalic vein outﬂow was
associated with fewer access failures, fewer interventions postoperatively, and lower rates of arm swelling (P < .01).
Conclusions: Creating a basilic vein transposition for vascular access utilizing axillary artery inﬂow is a good option for
patients with severe peripheral vascular disease. It offers a high patency rate and the prevention of DASS. Retrograde
basilic vein outﬂow through the median cubital and cephalic vein is associated with the best outcome and is the rec-
ommended conﬁguration. (J Vasc Surg 2013;58:1305-9.)Creating a safe and functional hemodialysis vascular
access in patients with severe peripheral vascular disease
while also avoiding dialysis access-associated ischemic steal
syndrome (DASS) may be difﬁcult. Vascular access
surgeons are frequently faced with evaluating patients
referred for permanent dialysis access who are clinically at
signiﬁcant risk for developing DASS. These patients are
most often diabetic with peripheral neuropathy and
profound atherosclerotic peripheral vascular disease
involving the brachial, ulnar, and radial arteries. They
may have a history of a previous vascular access ligation
due to hand ischemia with ulceration, pain, loss of func-
tion, or even amputation. Palpable distal pulses are absent
and ultrasound shows heavily calciﬁed brachial and distalthe Department of Surgery, University of Oklahoma College of
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in our experience, the axillary arteries are relatively normal
and free of occlusive disease in these circumstances.
Proximalization of the arterial inﬂow for an existing
vascular access is well established as an effective treatment
for DASS.1 Based on the success of our initial experience
using the axillary artery for establishing a safe and func-
tional autogenous vascular access in patients at high risk
for DASS; we have continued to employ this approach to
minimize the risk of steal syndrome.2 This report updates
our experience and patient outcomes with primary
construction of a vascular access using the axillary artery
for inﬂow to prevent distal ischemia in patients at high
risk for DASS.
METHODS
We retrospectively reviewed our vascular access database
to identify all patients who had undergone a primary arterio-
venous ﬁstula (AVF) transposition procedure utilizing the
axillary artery for inﬂow during a 3-year period. Peritoneal
dialysis had been considered for each patient but was not
feasible. All patients had severe peripheral vascular disease
as evidenced by the absence of palpable brachial, radial, and
ulnar pulses. Our initial evaluation for each patient included
vessel mapping with ultrasound performed by the operating
surgeon.3 However, other surgeons may use vascular lab-
oratory vessel mapping and/or venography. We do not rou-
tinely obtain central venography. If arm swelling develops1305
Fig 1. Schematic images of axillary artery inﬂow arteriovenous
ﬁstula (AVF) basilic vein transpositions. Type I had venous outﬂow
through the cephalic vein via the median cubital vein. Type II
venous outﬂow was through the forearm basilic and collateral veins
into the deep brachial vein(s). Retrograde ﬂow through the basilic
vein for both types was established with a valvulotome prior to
constructing the axillary artery anastomosis.
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system as necessary.4 Physical and ultrasound examinations
predicted adequate proximal inﬂow for these patients, and
we did not obtain routine preoperative arteriograms or non-
invasive arterial testing. Our subsequent intraoperative clin-
ical ﬁndings of the state of the axillary artery have
conﬁrmed these expectations. The ultrasound examination
included the axillary artery, but its diameter was not routinely
recorded.We reliably found the axillary artery to be relatively
free of atherosclerotic disease and larger in diameter than the
brachial artery.No patients were excluded, and all individuals
had an autogenous access constructed.
All operations were outpatient procedures at a univer-
sity afﬁliated tertiary medical center. Our surgical practice
includes a broad referral area of complex dialysis access
patients and individuals with failed access procedures. We
use ultrasound again in the operating room to conﬁrm
the operative plan and mark incision sites. In addition to
intravenous sedation and local anesthetic inﬁltration,
a regional sensory block was administered by the surgeon
through the axillary incision at the start of the operation.
An end-to-side axillary artery AVF anastomosis was con-
structed and limited in size to approximately 4 mm (target
size#75% of the diameter of the axillary artery5). The teres
major muscle margin was not speciﬁcally identiﬁed during
the arterial exposure to conﬁrm the transition from axillary
to brachial artery; however, the inﬂow anastomosis was
constructed proximal to the deep brachial artery origin.
Axillary arteries were approximately 6-8 mm in diameter,
and the venous conduits selected were$4 mm in diameter.
Each new access outﬂow conﬁguration varied with the
available venous outﬂow vein identiﬁed during preopera-
tive ultrasonographic evaluation. The completed AVF was
either a reversed ﬂow basilic vein transposition supple-
mented by valvulotomy (n ¼ 22), a translocated reversed
basilic vein (n ¼ 4), a cephalic vein harvested into the fore-
arm and placed in a loop conﬁguration for axillary artery
inﬂow (n ¼ 3), or a translocated reversed saphenous vein
(n ¼ 1). AVF venous outﬂow patterns were grouped into
two types for analysis. Type I (n ¼ 12) had nonobstructed
ﬂow into the median cubital and cephalic veins. Type II
(n ¼ 18) had outﬂow through the forearm basilic and
collateral veins into the brachial veins (Fig 1).
Ultrasound was key in selecting the venous outﬂow
conduit and planning the surgical procedure. When
a reversed ﬂow basilic vein transposition was used, the
vein was harvested well into the axilla using a lighted
retractor to gain the required length necessary for a prox-
imal anastomosis. Prior to constructing the inﬂow anasto-
mosis, a Leather valvulotome was used to disrupt the
valves, permitting retrograde ﬂow. After irrigation of the
vein conﬁrmed all valve leaﬂets to be incompetent, the
vein was tunneled in a superﬁcial path for later cannulation.
Additional technical details, photos, and schematic images
are shown in our initial report.2 In the seven patients where
a translocated vein was harvested, the vein was reversed and
valvulotomy was not necessary; however, the potential
outﬂow conﬁgurations remained the same.Primary patency was deﬁned as the time in months of
uninterrupted patency and without intervention. Primary
assisted patency was the time of uninterrupted patency
from the original AVF construction but in which an inter-
ventional procedure was utilized. Cumulative (secondary)
patency was the period from the original AVF construction
until thrombosis or the study period was completed,
regardless of interventions employed. Access ﬂow rates
were measured by ultrasound (Terason t2000 and t3000,
Teratech Corporation, Burlington, Mass) prior to the
initial access cannulation. Flow was measured using a Tera-
son 12L5V (Teratech Corporation) linear array transducer
at an insonation angle of 60 degrees. Patency in this report
refers to a functional vascular access used for hemodialysis.
Statistical analysis was performed utilizing a Student t-test
for comparisons between groups with Prism 4 software
(GraphPad Software, La Jolla, Calif). Data are expressed,
where applicable, as standard error of the mean (SEM)
and access patency displayed using the method of
Kaplan-Meier. The study was approved by our institutional
review board.
RESULTS
Thirty patients with a mean age of 60 years (range, 31-
83 years; SEM, 2.6) underwent successful primary axillary
artery inﬂow procedures during a 3-year period. Of these,
23 (77%) were female and 25 (83%) were diabetic.
Twenty-one patients (70%) had previous dialysis access
procedures and ten (33%) were obese. All patients lacked
Table I. Patient comorbidities
Patient comorbidities
Number of patients
(n ¼ 30), No. (%)
Diabetes 25 (83)
Previous access operations 21 (70)
Hypertension 21 (70)
Heart disease 15 (50)
Previous amputation 12 (40)
History of access-related hand ischemia 11 (37)
Obesity 10 (33)
Stroke 4 (13)
Fig 2. Kaplan-Meier analysis for patency of axillary artery inﬂow
arteriovenous ﬁstulas (AVFs). The number of patients at risk for
primary, assisted, and cumulative patency, respectively, is indicated
at the bottom of the graph. Standard errors were <10%
throughout the time interval shown.
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tion of the operating vascular surgeon. Ultrasonography
demonstrated small calciﬁed radial and ulnar arteries in
the presence of relatively normal axillary arteries. The
brachial artery mean internal luminal diameter as measured
by ultrasound was 2.2 mm (range, 1.6-3.6 mm; SEM,
0.15). Patient comorbidities are shown in Table I. Each
patient had severe peripheral vascular disease in all extrem-
ities. Heart disease included those patients with docu-
mented coronary artery occlusive disease, congestive
heart failure, or who have had a previous myocardial infarc-
tion, coronary stents, or coronary artery bypass. Site selec-
tion for the planned access was based on ultrasound
imaging of available venous outﬂow conduit, previous
grafts/scarring, past DASS, and arterial anatomy.
Patients were followed in the ofﬁce until the access was
in use and thereafter for any sign of dysfunction detected
during regular dialysis and access maintenance at each
unit. Access ﬂow measurements were obtained during
ultrasound examination prior to initiation of dialysis and
for any problem with maturation or function. Detection
of inadequate access ﬂow volume (<500 mL/min),
stenosis, arm swelling, or other abnormalities prompted
a ﬁstulogram. All interventions were based on a diagnostic
ﬁstulogram and percutaneous balloon angioplasty when
indicated. The assessment postoperatively for the presence
or absence of DASS was clinical and included an evaluation
for any symptoms or physical ﬁndings of ischemia or
change from preoperative status. Preoperative and postop-
erative data were collected by direct patient interview and
examination and physician contact, in addition to patient
contact through dialysis coordinators, dialysis nurses, and
our ofﬁce nursing staff.
Three individuals died at 2, 14, and 19 months
following surgery, none related to vascular access. The
average follow-up of this patient group was 7 months
(range, 1-25 months; SEM, 1.3). Three AVFs failed after
1, 5, and 7 months and could not be salvaged. Life-table
analysis of primary, primary assisted, and cumulative
patency demonstrated functional patency rates of 57%,
78%, and 87% at 1 year, respectively (Fig 2). Importantly,
no patient developed DASS postoperatively.
Patency was signiﬁcantly inﬂuenced by venous outﬂow
conﬁguration. Type I ﬁstulas had no access failures while
patients with type II ﬁstulas experienced three access fail-
ures that could not be salvaged (0% vs 16%; P < .01).
Type I AVFs also required fewer interventions to maintain
patency (8% vs 77%; P < .01). In addition, type I patients
had lower rates of clinically signiﬁcant arm swelling, which
required intervention (0% vs 38%; P < .01). Postoperative
ﬁstula ﬂow volumes did not signiﬁcantly differ between
type I and type II (623 vs 570 mL/min; P ¼ .29). Both
outﬂow conﬁgurations were equally effective in avoiding
DASS (Table II).
DISCUSSION
Patients with severe peripheral vascular disease are at
higher risk for DASS after creation of a vascular access.Most such individuals are diabetic and, like those in this
study, lack palpable distal pulses. These patients frequently
have had previous access operations that failed or required
access ligation because of DASS. They may have amputa-
tions or disability because of previous access-related
ischemia. Although adequate veins for a new AVF creation
may be available, small calciﬁed brachial, radial, and ulnar
arteries present a signiﬁcant risk of developing DASS. In
contrast, the axillary artery is larger and generally free of
signiﬁcant occlusive disease in these individuals. In these
circumstances, the axillary artery can provide reliable
vascular access inﬂow.
Preventing and minimizing the risk of DASS is the best
method of dealing with this potentially hand threatening
complication of hemodialysis vascular access procedures.
The most common way of avoiding DASS is construction
Table II. Complications
Type I
(n ¼ 12), %
Type II
(n ¼ 18), %
P
value
Patients developing DASS 0 0
Intervention required 8.3 77 <.01
Postoperative arm edema 0 38 <.01
Access failure 0 16 <.01
DASS, Dialysis access-associated ischemic steal syndrome.
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a distal radiocephalic or proximal radial artery AVF.6,7
The risk of DASS requiring intervention for these distal
AVFs is 1%-2%.8 However, when a radial artery inﬂow
access is not feasible because of arterial disease and/or
occluded venous outﬂow opportunities, a more proximal
arterial inﬂow site will be needed. Unfortunately, approxi-
mately 6%-12% of brachial artery inﬂow access procedures
will require some form of intervention for DASS, and this
percentage is likely much higher in patients with severe
peripheral vascular disease.8
Procedures to treat established DASS while maintaining
a functional access include banding (ﬂow restriction),
revision to distal inﬂow, direct conversion of the anastomosis
from brachial to radial artery, distal revascularization and
interval ligation, and inﬂow proximalization.9-12 Inﬂow
proximalization works much like the distal revascularization
and interval ligation procedure but has the beneﬁt of
avoiding ligation of the brachial artery.1,8,13 Success with
treatingDASS using inﬂow proximalization led us to employ
this technique when constructing a primary autogenous
access in patients believed to be at high risk for DASS.2
The axillary artery is signiﬁcantly larger and more compliant
than the brachial artery in these individuals and, importantly,
is relatively free of the calciﬁc occlusive disease found
in the brachial and distal arteries, allowing creation of
a functional access that will not result in DASS.
Venous outﬂow is a key element of successful vascular
access operations. Type I outﬂow is characterized by
a patent cephalic vein in direct connection with the arteri-
alized basilic vein by retrograde access ﬂow through the
median cubital and median cephalic veins. Although it
did not reach statistical signiﬁcance, most likely because
of the relatively small number of patients, our results
suggest higher ﬂow rates with this conﬁguration. Type II
constructions, on the other hand, depended on outﬂow
through multiple smaller communicating branches into
the brachial veins. Access failure, need for interventions,
and signiﬁcant arm edema were signiﬁcantly worse with
this conﬁguration, and its use is not recommended.
When a type I outﬂow conﬁguration is not possible in
such high risk patients, we now harvest the basilic vein,
reverse the orientation, and construct the access with axil-
lary inﬂow and a distal outﬂow anastomosis to the largest
brachial vein.
Pulse volume recordings, ﬁnger pressures, digital/
brachial indices, arteriography, computed tomographyimaging, and pulse oximetry are important tools that can
be used in the evaluation and treatment planning for estab-
lished DASS patients. However, predicting which indi-
vidual patient will develop ischemic symptoms and
complications prior to creating a new vascular access
remains difﬁcult. Prospective studies with deﬁnitive DASS
risk prediction models to guide operative decision making
are not available. Clinical judgment remains our method
of selecting patients for primary axillary inﬂow vascular
access procedures. Peritoneal dialysis should also be consid-
ered as an alternative dialysis option when possible in
appropriate patients. The concept of primary vascular
access proximalization to avoid DASS should also be appli-
cable for patients where no venous conduit is available and
placement of an AV graft is necessary.
CONCLUSIONS
Creating an autogenous vascular access utilizing axil-
lary artery inﬂow is a good option for patients with severe
peripheral vascular disease, offering a high patency rate and
the prevention of DASS. Venous outﬂow through a retro-
grade basilic vein transposition into the median cubital and
median cephalic veins is associated with the best outcome
and is the recommended conﬁguration.AUTHOR CONTRIBUTIONS
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